Historique
Document multimédia
Gender and drugs in Europe
Titre de série :
Frequently asked questions (FAQ)
Auteur(s) :
EUDA (European Union Drugs Agency)
Année
2026
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
Domaine :
Alcool ; Drogues illicites ; Tabac / e-cigarette
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
UNION EUROPEENNE
;
EUROPE
Thésaurus mots-clés
DIFFERENCE DE GENRE
;
SEXE
;
PRODUIT ILLICITE
;
STIGMATISATION
;
VIOLENCE
;
CONSOMMATION
;
PRISE EN CHARGE
;
MORTALITE
;
PREVALENCE
;
ALCOOL
;
TABAC
;
POLITIQUE
;
INTERVENTION
;
ACCES AUX SOINS
Résumé :
These pages answer the questions most often asked about gender and drugs, with a focus on the situation in Europe.
Men are more likely than women to use substances, including illicit drugs. There are notable differences in patterns of use and potential consequences of drug use. However, the phenomenon of drug use has historically been treated as a 'gender-neutral' issue, thereby potentially overlooking significant differences between women and men in all their diversity.
When gender has been considered, the focus has largely been on women and issues specific to them, such as drug use during pregnancy. This has left a considerable gap in the analysis of gender differences in drug use and the interventions addressing them.
A lack of comprehensive research and monitoring on gender differences in drug use and its consequences makes it difficult to assess needs accurately and develop appropriate interventions.
These FAQs provide an overview of the main concepts relating to gender and drugs, a summary of available data and a description of gender-responsive interventions reported by EU Member States and Norway and Türkiye.
Most of the data discussed in these FAQs are based on sex at birth. Information on gender identity and drugs remains scarce and is included where possible. [Editor's abstract]
Men are more likely than women to use substances, including illicit drugs. There are notable differences in patterns of use and potential consequences of drug use. However, the phenomenon of drug use has historically been treated as a 'gender-neutral' issue, thereby potentially overlooking significant differences between women and men in all their diversity.
When gender has been considered, the focus has largely been on women and issues specific to them, such as drug use during pregnancy. This has left a considerable gap in the analysis of gender differences in drug use and the interventions addressing them.
A lack of comprehensive research and monitoring on gender differences in drug use and its consequences makes it difficult to assess needs accurately and develop appropriate interventions.
These FAQs provide an overview of the main concepts relating to gender and drugs, a summary of available data and a description of gender-responsive interventions reported by EU Member States and Norway and Türkiye.
Most of the data discussed in these FAQs are based on sex at birth. Information on gender identity and drugs remains scarce and is included where possible. [Editor's abstract]
Autre(s) lien(s) :
News release (06/03/2026)